Also listed on The Regents of the University of California, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 11, 2026 · Medium confidence
20-year base term ended Oct 31, 2023
Why Medium: A parent in the chain could not be resolved.
Held by Prothena Biosciences Limited
Filed Aug 9, 2004 as application 10/915,214 · Granted Apr 15, 2014
Base term plus 1137 days of patent term adjustment (USPTO delay)
Today
2003
2026
Clock starts
Oct 31, 2003
Oct 31, 2003
Term ends
Dec 11, 2026
Dec 11, 2026
Granted
Apr 15, 2014
Apr 15, 2014
base term
patent term adjustment
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,137
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
96
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1137 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 31, 2003, when the earliest non-provisional application in its chain was filed (this one was filed Aug 9, 2004); a parent in its chain could not be resolved (the next row) | Oct 31, 2023 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +1137 days, USPTO patent term adjustment record | Dec 11, 2026 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 11, 2026 | Medium confidence |
Partial family
| US 6,787,523 | Term ended no later than Nov 2018 | no later than Nov 2018 |
| US 7,964,192 | Term ended no later than Nov 2018 | no later than Nov 2018 |
| Application 09/580,015 | No file history here not computed | not computed |
| US 6,761,888 | Term ended no later than May 2020 | no later than May 2020 |
| Application 09/580,019 | No file history here not computed | not computed |
| Application PCT/US2000/014810 | PCT application no patent term | no patent term |
| US 6,923,964 | Term ended Apr 2020 | Apr 2020 |
| Application 09/723,713 | No file history here not computed | not computed |
8 of 96 applications in this family shown, earliest filings first. Partial: 18 of the 96 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 18, 2004 Reel 15266, frame 996 | Schenk, Dale B. | Elan Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Oct 18, 2004 Reel 15267, frame 4 | Masliah, Eliezer | The Regents of the University of California | Assignment of Assignor's Interest |
| Jan 11, 2012 Reel 27519, frame 9 | Elan Pharmaceuticals, Inc. | Crimagua Limited | Assignment of Assignor's Interest |
| Jan 11, 2012 Reel 27519, frame 144 | Crimagua Limited | Janssen Alzheimer Immunotherapy | Assignment of Assignor's Interest |
| Jan 23, 2014 Reel 32033, frame 105 | Janssen Alzheimer Immunotherapy | Neotope Biosciences Limited | Assignment of Assignor's Interest |
| Aug 26, 2016 Reel 39558, frame 335 | Neotope Biosciences Limited | Prothena Biosciences Limited | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Dec 2026
Term ends Dec 11, 2026. No further fees fall due before then
Note
The 1137 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
15
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.